Lindus Health RAISES $55M in SERIES B FUNDING.
FEATURED NEWS

Lindus Health Awarded Funding From ARIA to Build Safe and Reliable AI for Clinical Trial Design

Lindus Health has been awarded funding from ARIA to develop a groundbreaking AI-assisted clinical trial design system with built-in safety guarantees, in collaboration with the University of Oxford, aiming to make trials faster, more reliable, and scientifically rigorous.

April 3, 2025

4

mins read

FEATURED NEWS

Lindus Health Awarded Funding From ARIA to Build Safe and Reliable AI for Clinical Trial Design

Lindus Health has been awarded funding from ARIA to develop a groundbreaking AI-assisted clinical trial design system with built-in safety guarantees, in collaboration with the University of Oxford, aiming to make trials faster, more reliable, and scientifically rigorous.

April 3, 2025

4

mins read

Lindus Health Awarded Funding From ARIA to Build Safe and Reliable AI for Clinical Trial Design

Lindus Health has been awarded funding from ARIA to develop a groundbreaking AI-assisted clinical trial design system with built-in safety guarantees, in collaboration with the University of Oxford, aiming to make trials faster, more reliable, and scientifically rigorous.

April 3, 2025

4

mins read

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

3/19/24

2

mins

Lindus Health aims to enhance the efficiency and success rates of CNS, neurology and psychiatric clinical trials with its "All-in-One CRO" offering to this market segment.

Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials

3/5/24

4

mins

Now available: Lindus Health's "All-In-One Metabolic CRO" to accelerate and streamline research in metabolic conditions such as diabetes, obesity, NASH, and more.

Running Effective DTx Studies in EU Markets, and Considerations for Cross Country Data Acceptance

2/27/24

1

mins

As more innovators join the digital therapeutics (DTx) landscape, understanding the intricacies of running clinical trials in Europe becomes increasingly essential. Tune in to discover how CROs in the DTx space help sponsors navigate these hurdles to successfully conduct clinical trials, delivering essential digital health interventions to patients faster.

Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies In the Space to Streamline Clinical Trials

2/1/24

3

mins

We're introducing our All-In-One CRO solution for the digital therapeutics market.

Interview: Robert Langer backs Lindus Health’s "anti-CRO" strategy

1/30/24

3

mins

Robert Langer and Lindus Health co-founder, Meri Beckwith, sat down for a Q&A session to discuss their new partnership and future direction of the company.

Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board

1/25/24

2

mins

We are thrilled to announce Robert S. Langer, co-founder of Moderna, has joined our advisory board.